Public Health
-
FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late
Ronnie Cohen In April, a dozen years after a federal agency classified formaldehyde a human carcinogen, the Food and Drug…
Read More » -
CVS Heath (CVS) Q4 2023 earnings
CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit…
Read More » -
Colorado avanza con proyectos para conectar a trabajadores agrícolas con servicios de salud mental
Legisladores de Colorado han propuesto un par de medidas que, dicen, mejorarán el acceso a recursos de salud mental para…
Read More » -
Even in Bright-Blue California, Abortion Is on the Ballot
The race to replace the late Democratic Sen. Dianne Feinstein is in full swing in California. Although the state enshrined…
Read More » -
Colorado Moves to Connect Agricultural Workers With Mental Health Resources
Vignesh Ramachandran If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide &…
Read More » -
GE Healthcare (GEHC) stock finally gets some respect after Q4 earnings
Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with…
Read More » -
Halfway Through ‘Unwinding,’ Medicaid Enrollment Is Down About 10 Million
We’re halfway through the Medicaid “unwinding,” in which states are dropping people from the government health insurance program for the…
Read More » -
Eli Lilly (LLY) earnings Q4 2023
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. …
Read More » -
Is Housing Health Care? State Medicaid Programs Increasingly Say ‘Yes’
States are plowing billions of dollars into a high-stakes health care experiment that’s exploding around the country: using scarce public…
Read More » -
Novo Nordisk parent to buy Catalent to expand Wegovy supply
Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker Novo…
Read More »